Astigmatic correcting IOL


Rotational stability is key to success

Rotational stability can be attributed to both bio-mechanical as well as bio-material properties as it involves lens capsular dynamics. In the case of the Tecnis 1-piece IOL the bio-mechanical stability advantage is due to the 3 points of contact to the lens capsule referred to as the 'tri-fix' design with the 2 haptics and the posterior surface of the optic due to the posterior off-set or step vaulting between the optic and the haptics. The bio-material properties of the Tecnis 1-peice designed to enhance stability are resistance to compression of the haptics in the capsular bag and an adherence between the optical surface and the capsular wall.

Analysing rotational stability

Fourteen sites were included in the trial that were based in the US and Canada and in total 174 eyes were implanted with the lens. Data in the trial was included for all toric first eyes from both study arms that had evaluable images between specified stability time points. This included 156 eyes, however, these did not necessarily have photographic data available for every follow up visit, which were set at 1 day, 1 week, 1, 3 and 6 months. "The FDA wanted to display stability over a 3 month interval so the initial 2 data points were 1 day to 3 months and 3 months to 6 months," said Dr Nixon.

The digital slit-lamp photographs were analysed by a validated custom and proprietary software that uses iris and/or scleral landmarks to align images from later time points to baseline. As a comparison, the team used the ANSI standard (Z80.30), which defines toric lens stability as >90% of lenses rotating ≤5° between visits that are 3 months apart.2

"When the study data was reviewed, the lens stability was so impressive that even the 1 day to 6 months exceeded the ANSI (Z80.30) guidelines for Toric IOLs," he added.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Thomas Bosshard stands at the Oertli Instruments booth at the ESCRS meeting
Eva Kim, MD, speaks about her presentation on ICL versus CLE at the Women in Ophthalmology Summer Symposium 2023 in Marco Island, Florida.
Trukera Medical rebranding ushers in new era of expansion into cornea market
Related Content
© 2023 MJH Life Sciences

All rights reserved.